L Nagy

578 total citations
30 papers, 451 citations indexed

About

L Nagy is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, L Nagy has authored 30 papers receiving a total of 451 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Immunology. Recurrent topics in L Nagy's work include Curcumin's Biomedical Applications (4 papers), RNA Interference and Gene Delivery (3 papers) and Chemical Reactions and Isotopes (3 papers). L Nagy is often cited by papers focused on Curcumin's Biomedical Applications (4 papers), RNA Interference and Gene Delivery (3 papers) and Chemical Reactions and Isotopes (3 papers). L Nagy collaborates with scholars based in Hungary, United States and Japan. L Nagy's co-authors include László G. Puskás, Gábor J. Szebeni, László Hackler, Róbert Alföldi, Nóra Faragó, Klára Kitajka, Iván Kanizsai, József Á. Balog, Csaba Vízler and Béla Ózsvári and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

L Nagy

30 papers receiving 443 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L Nagy Hungary 13 177 90 71 66 54 30 451
Hanifeh Mirtavoos‐Mahyari Iran 9 322 1.8× 84 0.9× 143 2.0× 128 1.9× 52 1.0× 21 760
Zheng Sun China 11 165 0.9× 29 0.3× 54 0.8× 12 0.2× 26 0.5× 24 369
Liliána Z. Fehér Hungary 13 192 1.1× 57 0.6× 40 0.6× 18 0.3× 42 0.8× 25 429
Ester Carballo‐Jane United States 14 239 1.4× 24 0.3× 31 0.4× 19 0.3× 46 0.9× 22 481
Aimin Cai China 14 245 1.4× 67 0.7× 47 0.7× 8 0.1× 52 1.0× 20 493
Duolu Li China 14 299 1.7× 48 0.5× 68 1.0× 14 0.2× 18 0.3× 32 522
Dorota Przybylska Poland 9 191 1.1× 49 0.5× 35 0.5× 30 0.5× 135 2.5× 14 403
Song Qiao China 14 229 1.3× 63 0.7× 41 0.6× 60 0.9× 83 1.5× 54 624
Yuna Tong China 9 259 1.5× 41 0.5× 23 0.3× 7 0.1× 39 0.7× 14 517

Countries citing papers authored by L Nagy

Since Specialization
Citations

This map shows the geographic impact of L Nagy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Nagy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Nagy more than expected).

Fields of papers citing papers by L Nagy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L Nagy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Nagy. The network helps show where L Nagy may publish in the future.

Co-authorship network of co-authors of L Nagy

This figure shows the co-authorship network connecting the top 25 collaborators of L Nagy. A scholar is included among the top collaborators of L Nagy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L Nagy. L Nagy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Szebeni, Gábor J., Róbert Alföldi, L Nagy, et al.. (2023). Introduction of an Ultraviolet C-Irradiated 4T1 Murine Breast Cancer Whole-Cell Vaccine Model. Vaccines. 11(7). 1254–1254. 5 indexed citations
2.
Kovács, B, László G. Puskás, L Nagy, et al.. (2022). Blocking the Increase of Intracellular Deuterium Concentration Prevents the Expression of Cancer-Related Genes, Tumor Development, and Tumor Recurrence in Cancer Patients. Cancer Control. 29. 2895487011–2895487011. 9 indexed citations
3.
Sompol, Pradoldej, Jenna L. Gollihue, Susan D. Kraner, et al.. (2021). Q134R: Small chemical compound with NFAT inhibitory properties improves behavioral performance and synapse function in mouse models of amyloid pathology. Aging Cell. 20(7). e13416–e13416. 10 indexed citations
4.
Boros, László G., Ildikó Somlyai, B Kovács, et al.. (2021). Deuterium Depletion Inhibits Cell Proliferation, RNA and Nuclear Membrane Turnover to Enhance Survival in Pancreatic Cancer. Cancer Control. 28. 1149434919–1149434919. 21 indexed citations
5.
Csécsei, Péter, Réka Várnai, L Nagy, et al.. (2019). L-arginine pathway metabolites can discriminate paroxysmal from permanent atrial fibrillation in acute ischemic stroke. Ideggyógyászati Szemle. 72(3-4). 79–88. 8 indexed citations
6.
Alföldi, Róbert, József Á. Balog, Nóra Faragó, et al.. (2019). Single Cell Mass Cytometry of Non-Small Cell Lung Cancer Cells Reveals Complexity of In Vivo and Three-Dimensional Models over the Petri-Dish. Cells. 8(9). 1093–1093. 23 indexed citations
7.
Balog, József Á., László Hackler, Á. Kovács, et al.. (2019). Single Cell Mass Cytometry Revealed the Immunomodulatory Effect of Cisplatin Via Downregulation of Splenic CD44+, IL-17A+ MDSCs and Promotion of Circulating IFN-γ+ Myeloid Cells in the 4T1 Metastatic Breast Cancer Model. International Journal of Molecular Sciences. 21(1). 170–170. 39 indexed citations
8.
Kovács, Á., et al.. (2018). Synthesis of N-peptide-6-amino-D-luciferin Conjugates. Frontiers in Chemistry. 6. 120–120. 2 indexed citations
9.
Simon, Éva, et al.. (2017). Szívinfarktusos betegek akut és rehabilitációs ellátása Győr-Moson-Sopron és Vas megyében. 47(6). 425–430. 3 indexed citations
10.
Hackler, László, Béla Ózsvári, Péter Sipos, et al.. (2016). The Curcumin Analog C-150, Influencing NF-κB, UPR and Akt/Notch Pathways Has Potent Anticancer Activity In Vitro and In Vivo. PLoS ONE. 11(3). e0149832–e0149832. 51 indexed citations
11.
Nagy, L, Gábor J. Szebeni, Péter Sipos, et al.. (2015). Curcumin and Its Analogue Induce Apoptosis in Leukemia Cells and Have Additive Effects with Bortezomib in Cellular and Xenograft Models. BioMed Research International. 2015. 1–11. 24 indexed citations
12.
Tóth, Andrea E., Fruzsina R. Walter, Alexandra Bocsik, et al.. (2014). Edaravone Protects against Methylglyoxal-Induced Barrier Damage in Human Brain Endothelial Cells. PLoS ONE. 9(7). e100152–e100152. 36 indexed citations
13.
Nagy, L, Eszter Molnár, Iván Kanizsai, et al.. (2013). Lipid droplet binding thalidomide analogs activate endoplasmic reticulum stress and suppress hepatocellular carcinoma in a chemically induced transgenic mouse model. Lipids in Health and Disease. 12(1). 175–175. 10 indexed citations
14.
Jánosi, András, Béla Merkely, Péter Polgàr, et al.. (2013). Szívinfarktus miatt kezelt betegek korai és késői prognózisa. Magyar Infarctus Regiszter Vizsgálat | Short and long term prognosis of patients with myocardial infarction. Hungarian Myocardial Infarction Registry. 9 indexed citations
15.
Lukács, L, et al.. (1996). [Long-term results of surgical treatment of cardiac myxomas].. PubMed. 137(22). 1187–90. 1 indexed citations
16.
Glavin, Gary B., et al.. (1996). Isolated rat gastric mucosal cells: optimal conditions for cell harvesting, measures of viability and direct cytoprotection.. Journal of Pharmacology and Experimental Therapeutics. 276(3). 1174–1179. 5 indexed citations
17.
Szabó, Sándor & L Nagy. (1992). Pathways, mediators and mechanisms of gastroduodenal mucosal injury.. PubMed. 80(1-4). 9–21. 4 indexed citations
18.
Nagy, L, et al.. (1990). The extent of bile reflux and development of gastric cancer after resections in rat.. PubMed. 31(4). 339–46. 2 indexed citations
19.
Lengyel, M, et al.. (1983). [Fenestration of the pericardium in uremic pericardial effusion].. PubMed. 124(42). 2545–7. 1 indexed citations
20.
Nagy, L, et al.. (1964). [RECURRENT RECTAL NEURINOMA].. PubMed. 105. 1188–90. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026